These risks appear to be present regardless of a person's age or health at the time of infection.

These elevated risks extend well beyond the initial infection period, researchers caution.

These findings are not exclusive to severe cases of the virus and have been observed in individuals who reported having more moderate infections.

Researchers have identified what they believe could serve as imaging biomarkers that predict recovery from anosmia after contracting the virus. 

Although serious adverse events related to COVID-19 vaccines are rare, some are life-threatening. It is important that radiologists are aware of how these complications present.

Researchers have used 7T MRI to demonstrate that former COVID-19 inpatients are susceptible to persistent brainstem abnormalities associated with long-haul COVID symptoms.

Some of the findings observed have also been reported in patients who have multiple sclerosis, “which could suggest partially shared pathophysiological substrates of fatigue symptoms,” researchers indicated. 

The CDC estimates that just under 7% of adults in the United States continue to struggle with symptoms of long COVID.